Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Chemomab Therapeutics Ltd...

    NASDAQ: CMMB · Real-Time Price · USD
    1.17
    -0.02 (-1.98%)
    At close: Jun 27, 2025, 3:59 PM
    1.17
    -0.02%
    After-hours: Jun 27, 2025, 04:00 PM EDT

    Chemomab Therapeutics Statistics

    Share Statistics

    Chemomab Therapeutics has 943.14K shares outstanding. The number of shares has increased by 32.62% in one year.

    Shares Outstanding

    n/a
    		 943.14K

    Shares Change (YoY)

    n/a
    		 32.62%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.28%

    Shares Floating

    n/a
    		 754.42K

    Failed to Deliver (FTD) Shares

    n/a
    		 12,848

    FTD / Avg. Volume

    n/a
    		 7.82%

    Short Selling Information

    The latest short interest is 66.04K, so 0.35% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 66.04K

    Short % of Shares Out

    n/a
    		 0.35%

    Short % of Float

    n/a
    		 0.35%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -2330.15 and the forward PE ratio is -3.23. Chemomab Therapeutics's PEG ratio is 37.56.

    PE Ratio

    n/a
    		 -2330.15

    Forward PE

    n/a
    		 -3.23

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 2.4

    P/FCF Ratio

    n/a
    		 -2.11

    PEG Ratio

    n/a
    		 37.56
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Chemomab Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 4.98

    Quick Ratio

    n/a
    		 4.98

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -22.08

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-697.25

    Employee Count

    n/a
    		 20

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 22.55% in the last 52 weeks. The beta is 0.62, so Chemomab Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.62

    52-Week Price Change

    n/a
    		 22.55%

    50-Day Moving Average

    n/a
    		 1.28

    200-Day Moving Average

    n/a
    		 1.54

    Relative Strength Index (RSI)

    n/a
    		 40

    Average Volume (20 Days)

    n/a
    		 164,338

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -14.74K

    Net Income

    n/a
    		 -13.95K

    EBITDA

    n/a
    		 -14.67K

    EBIT

    n/a
    		 -14.74K

    Earnings Per Share (EPS)

    n/a
    		 -0.78
    Full Income Statement

    Balance Sheet

    The company has 6.07M in cash and 324K in debt, giving a net cash position of 5.75M.

    Cash & Cash Equivalents

    n/a
    		 6.07M

    Total Debt

    n/a
    		 324K

    Net Cash

    n/a
    		 5.75M

    Retained Earnings

    n/a
    		 -102.62M

    Total Assets

    n/a
    		 16.96M

    Working Capital

    n/a
    		 12.82M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.46M and capital expenditures 0, giving a free cash flow of -15.39M.

    Operating Cash Flow

    n/a
    		 -15.46M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -15.39M

    FCF Per Share

    n/a
    		 -0.04
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CMMB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CMMB is $8.5, which is 614.3% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 614.3%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 17, 2021. It was a backward split with a ratio of 1:16.

    Last Split Date

    n/a
    		 Mar 17, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:16

    Scores

    Altman Z-Score

    n/a
    		 -10.14

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist